Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Current Opinion in Molecular Therapeutics|October 13, 2007
mRNA-based gene transfer as a tool for gene and cell therapyViggo F I Van Tendeloo, Peter Ponsaerts, Zwi N BernemanThe Oncologist|February 1, 2012
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trialsAnn Van Driessche, Zwi N Berneman, Viggo F I Van TendelooClinical & Developmental Immunology|March 5, 2008
Regulatory T cells and human diseaseNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.Journal of Leukocyte Biology|August 23, 2007
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cellsNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.The Oncologist|March 18, 2009
Immunotherapy of acute myeloid leukemia: current approachesEvelien L J M Smits, Zwi N Berneman, Viggo F I Van TendelooHuman Vaccines|March 23, 2011
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answersSébastien Anguille, Eva Lion, Evelien Smits, et al.Bulletin Du Cancer|April 9, 2008
Immunotherapy of hematological malignancies using dendritic cellsAnn L R Van de Velde, Zwi N Berneman, Viggo F I Van TendelooLeukemia Research|October 11, 2008
Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cellsEva Lion, Evelien L J M Smits, Zwi N Berneman, et al.The Oncologist|August 15, 2008
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapyEvelien L J M Smits, Peter Ponsaerts, Zwi N Berneman, et al.The Oncologist|August 22, 2012
NK cells: key to success of DC-based cancer vaccines?Eva Lion, Evelien L J M Smits, Zwi N Berneman, et al.Pageof 5